Sulopenem was superior to amoxicillin/clavulanate and ciprofloxacin in treating antimicrobial resistant uncomplicated urinary tract infections. The antibiotic was ...

FDA approved Orlynvah for the Tx of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis.

As assessed by Future Market Insights, among the drug type, quinolones held a market share of around 37.6% in the global market, in 2022. In 2022, the catheter associated urinary tract infections ...

Prime Minister Narendra Modi today virtually inaugurated India’s first active pharmaceutical ingredient (API) fermentation ...

The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...

The US Food and Drug Administration has approved a new oral antibiotic for treatment of uncomplicated urinary tract ...

This unit is a significant milestone in reducing India’s dependence on countries like China and Korea for APIs, as it will meet around 60 per cent of the domestic demand for potassium clavulanate API, ...

The Central Drug Regulatory Authority has found samples of four drugs, including widely used calcium supplement Shelcal 500 and Pan D, as spurious, while samples of 49 drugs were listed as not of ...

Ltd., Amoxicillin And Potassium Clavulanate Tablets by Alkem Health, Ciprofloxacin Tablets by Cadila Pharmaceuticals Limited and many more were identified as Not of Standard Quality (NSQ ...

Veterinarians should become familiar with new definitions and recommendations for managing urinary tract infections in dogs ...

Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum Therapeutics has scored a green light for its oral antibiotic sulopenem.

Indian drugmaker Wockhardt’s (BSE: 532300) today announced that the Subject Expert Committee (SEC) of Indian drug regulator, Central Drugs Standard Control Organization (CDSCO) has provided a ...